DoD Breast Cancer, Breakthrough Fellowship Award | W81XWH 19 BCRP BFA

Opportunity Information: Apply for W81XWH 19 BCRP BFA

The DoD Breast Cancer Breakthrough Fellowship Award is a postdoctoral-level funding opportunity from the Department of Defense (USAMRAA) designed to accelerate the careers of exceptionally promising early-stage scientists and physician-scientists while pushing forward bold, potentially transformative breast cancer research. It targets recent doctoral or medical graduates who are in, or about to begin, a postdoctoral fellowship and who can credibly be described as among the "best and brightest" in their peer group. The core idea is to pair a high-potential fellow with strong mentorship and a well-structured career development plan, so the fellow can generate impactful research outcomes and build the experience and track record needed to become an independent breast cancer investigator.

A central requirement of this award is impact. The program is not looking for incremental progress; it is looking for projects that could plausibly change the way breast cancer is understood, prevented, detected, or treated. The anticipated impact can be near-term or long-term, but the application must make a convincing case that the work could lead to a breakthrough or open a fundamentally better path than what is already approved or currently moving through the clinical development pipeline. Applicants are expected to be explicit about who ultimately benefits from the research, meaning they should clearly identify the breast cancer patient populations or at-risk groups that would be affected if the work succeeds.

The research strategy is expected to be innovative and appropriately ambitious, often fitting a high-risk/high-reward profile. Projects may be at an early conceptual stage or may be supported by preliminary data, but in either case the work must be positioned as having real potential to drive significant advances and, ideally, to move toward clinical translation over time. Even with innovative or exploratory projects, the program emphasizes strong scientific reasoning and rigor. Competitive applications are expected to lay out a clear rationale, logical approach, and a well-considered plan that includes experimental details, proper controls, a statistical plan, and thoughtful discussion of pitfalls and alternative approaches. In other words, novelty is valued, but it must be paired with credible execution.

A distinctive feature of the Breakthrough Fellowship Award is that the postdoctoral fellow is the Principal Investigator (PI) for the purposes of the application. The fellow is expected to take the lead in writing major components such as the project narrative and the researcher development plan, with guidance from the mentor. The PI does not necessarily need prior breast cancer-specific experience, but both the proposed project and the training and career development plan must be clearly centered on breast cancer. Reviewers will weigh the fellow's potential to become an independent breast cancer researcher by looking closely at qualifications and achievements, including first-author publications and strong letters of recommendation that demonstrate scientific talent, independence, and upward trajectory.

Mentorship is treated as a critical enabling factor rather than a formality. The mentor (or co-mentor) must have the expertise and experience necessary to support the fellow in breast cancer research and/or breast cancer patient care. The solicitation emphasizes evidence of active engagement in the field, such as recent publications and current peer-reviewed breast cancer funding, along with a clear commitment to guiding both the research and the fellow's development. If the primary mentor is not an established breast cancer researcher, the application must include a formal co-mentor who is. The program also acknowledges that not every strong scientist has an extensive history of mentoring trainees; in those cases, a particularly strong and well-justified researcher development plan can help offset a thinner mentoring record.

The researcher development plan is another major pillar of the award and must be individualized, breast cancer-focused, and tied directly to the fellow's path toward independence. Applications should describe the research environment and why it is well-suited for the proposed work and the fellow's growth, then lay out concrete development activities that build the skills, knowledge, and professional foundation needed for an independent career. Multidisciplinary training and research are encouraged, reflecting how modern breast cancer research often spans basic biology, engineering, data science, immunology, epidemiology, clinical insight, and other areas, but a multidisciplinary approach is not mandatory as long as the plan is coherent and compelling.

In terms of what research is allowed, the opportunity permits studies involving human subjects and human anatomical substances, but it explicitly does not allow clinical trials under this program announcement. That means applicants can propose human-relevant research (for example, analysis of patient samples, observational studies, or other non-trial human-subject work as permitted), but they cannot run an interventional clinical trial as part of this award.

Finally, the program requires relevance to military health. While the award supports breast cancer research that can benefit the broader American public, applicants must also articulate how the proposed work aligns with the healthcare needs of Service members, Veterans, military beneficiaries, and/or the public in ways consistent with Department of Defense priorities. Practically, this means the application should not treat military relevance as an afterthought; it should clearly connect the scientific aims and eventual impact to populations and health concerns that matter within the military health system context.

Administrative details in the posting indicate it was offered as a discretionary DoD funding opportunity (CFDA 12.420) using grant and/or cooperative agreement mechanisms, with an expected number of awards around 10 for that cycle. The listing shows an award ceiling of 0, which typically signals that applicants must refer to the full announcement for budget limits or that limits vary by category rather than being captured in the summary field. The opportunity number is W81XWH-19-BCRP-BFA, originally posted in January 2019 with a closing date in March 2019.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Breast Cancer, Breakthrough Fellowship Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Jan 22, 2019.
• Applicants must submit their applications by Mar 28, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 19 BCRP BFA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: